Information Journal Paper
APA:
Copy. (2018). miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 16(2), 1499-1504. SID. https://sid.ir/paper/736934/en
Vancouver:
Copy. miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA. EXPERIMENTAL AND THERAPEUTIC MEDICINE[Internet]. 2018;16(2):1499-1504. Available from: https://sid.ir/paper/736934/en
IEEE:
Copy, “miR-202 suppresses prostate cancer growth and metastasis by targeting PIK3CA,” EXPERIMENTAL AND THERAPEUTIC MEDICINE, vol. 16, no. 2, pp. 1499–1504, 2018, [Online]. Available: https://sid.ir/paper/736934/en